-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

636. Myelodysplastic Syndromes—Basic and Translational Studies: Poster II

Myelodysplastic Syndromes—Basic and Translational Studies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Ioanna Mosialou, PhD1*, Alvaro Cuesta-Dominiguez, PhD1*, Govind Bhagat, MD2, Ellin Berman, MD3, Azra Raza, MD2,4,5 and Stavroula Kousteni, PhD6

1Columbia University, New York, NY
2Columbia University Medical Center, New York, NY
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Columbia Presbyterian, New York, NY
5Department of Medicine, Columbia University Medical Center, New York, NY
6Columbia University, Glen Ridge, NJ

Tanzir Ahmed, PhD1, Tuoen Liu, MD, PhD2*, Kilannin Krysiak, PhD3*, Matthew Ndonwi, PhD1* and Matthew J. Walter, MD4

1Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Department of Biomedical Sciences, West Virginia School of Osteopathic Medicine, Lewisburg, WV
3Department of Medicine, Washington University School of Medicine, Saint Louis, MO
4Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO

David Muench, BS1, Amit Verma, MD2 and Lee Grimes3

1Molecular and Developmental Biology Graduate Program, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY
3Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Abhinav Goyal, MD1*, Mohammad Fahad B Asad, MD, MBBS1, Hassan Awada, MD2*, Mai Aly, M.D.3*, Cassandra M. Hirsch, BS3*, Bartlomiej P. Przychodzen, MSc3*, Tomas Radivoyevitch, PhD1*, Aziz Nazha, MD4, Sudipto Mukherjee, MD, PhD, MPH3, Mikkael A. Sekeres, MD, MS5, Jaroslaw P. Maciejewski, PhD, MD, FACP 6 and Yasunobu Nagata, MD, PhD3*

1Cleveland Clinic, Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland
2Cleveland Cl, Department of Hematology & Oncology Research, Taussig Cancer Center, Cleveland
3Department of Hematology and Oncology research, Cleveland Clinic, Cleveland
4Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland
5Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Taussig Cancer Center, Department of Hematology & Oncology Research,Cleveland Clinic, Cleveland

Sally Cole1*, Lumie Benard1*, Luis A. Carvajal, PhD1*, Amit Verma, MD2,3, Ulrich G. Steidl, MD, PhD2,4, Pedro Marques Ramos, PhD5*, Celine Pallaud, PhD5* and Britta Will, PhD6

1Albert Einstein College of Medicine, Bronx
2Department of Oncology, Montefiore Medical Center, Bronx, NY
3Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY
4Albert Einstein College of Medicine, Bronx, NY
5Novartis Pharmaceuticals, Basel, CHE
6Cell Biology, Albert Einstein College of Medicine, Bronx, NY

Frederic Picou, PhD1*, Christine Vignon, PhD1*, Joelle Hanna, MD2*, Sebastien Lachot, MD2*, Marie-Helene Estienne, PharmD2*, Amelie Foucault2*, Frederic Mazurier, PhD1*, Florence Rouleux-Bonnin, PhD1*, Fabrice Gouilleux, PhD1*, Jorge Domenech, MD-PhD1,2*, Emmanuel Gyan, MD-PhD1,3, Michaela Fontenay, MD, PhD4* and Olivier Herault, MD-PhD1,2

1CNRS UMR 7292, LNOx team, Tours, France
2University Hospital of Tours - Dept Biological Hematology, Tours, France
3University Hospital of Tours - Dept Hematology & Cell Therapy, Tours, France
4Assistance Publique-Hopitaux De Paris, Institut Cochin, Dept Biological Hematology, Paris, France

Abdullah Mahmood Ali, PhD 1, Yumin Huang2*, Diego Coutinho, BS1*, Brian Chernak, BA1*, Etienne De Clara, PhD1*, Daniela Hoehn, MD, PhD1, Joseph G. Jurcic, MD1, Mohandas Narla, DSc3, Xiuli An, MD, PhD2,4 and Azra Raza, MD1

1Department of Medicine, Columbia University Medical Center, New York, NY
2Laboratory of Membrane Biology, New York Blood Center, New York, NY
3Red Cell Physiology Laboratory, New York Blood Center, New York, NY
4College of Life Sciences, Zhengzhou University, Zhengzhou, China

Luise Hartmann, PhD*, Torsten Haferlach, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Anna Stengel, PhD, Melanie Zenger*, Kathleen Zieschang*, Wolfgang Kern, MD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Leylah M. Drusbosky, PhD1, Salah-Eddin Komrokji2*, Najla Al Ali, M.Sc3*, Neeraj Kumar Singh, B.Tech4*, Chandan Kumar, MT4*, Sumanth Vasista, BE4*, Diwyanshu Sahu, M.Sc.4*, Ganesh Naga, BT4*, Patil Dattatraya, MS4*, Taher Abbasi, MS, MBA5*, Shireen Vali, PhD5*, David A Sallman, MD6, Rami S. Komrokji, MD3 and Christopher R. Cogle, MD7

1Department of Medicine/Division of Hematology Oncology, University of Florida, Gainesville, FL
2H. Lee Moffitt Cancer Center, Tampa, FL
3Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
4Cellworks Research India Pvt. Ltd, Bangalore, India
5Cellworks Group Inc., San Jose, CA
6Moffitt Cancer Center, Tampa, FL
7University of Florida, Gainesville, FL

Pragya Srivastava, PhD1*, Elizabeth A. Griffiths, MD2, Prashant Singh, PhD3*, Eduardo Cortes Gomez, BS4*, Eunice S. Wang, MD2, LaurieAnn Ford, BS1*, Jianmin Wang, PhD4* and Michael J. Nemeth, PhD1

1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
2Roswell Park Cancer Institute, Buffalo, NY
3Department of Cancer Genetics and Genomics, Roswell Park Cancer Institute, Buffalo, NY
4Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY

Peipei Lin1,2*, Yanling Ren1*, Xinping Zhou1*, Chen Mei1*, Chao Hu1*, Yingwan Luo1*, Yile Zhou1,2*, Xiaomei Yan2*, Gang Huang, PhD2 and Hongyan Tong, PhD1*

1Department of Hematology, The First Affiliated Hospital Zhejiang University, Hangzhou, China
2Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Manja Meggendorfer, PhD, Wencke Walter, PhD*, Claudia Haferlach, MD, Wolfgang Kern, MD and Torsten Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Thomas Coats, MD1*, Alexander E Smith, PhD2*, Athanasios Mourikis3*, Tala Shahin3*, Austin G. Kulasekararaj, MBBS, MD, MRCP, FRCPath4*, Steve Best, PhD5*, Sneha Chitre3*, Richard Ellis6*, Nedyalko Petrov6*, Susanne Heck6*, Jonathan Michael Irish, PhD7*, Shahram Kordasti, MD, PhD4 and Ghulam J Mufti, DM, FRCP, FRCPath8*

1Haematology Department, King's College London, Carshalton, United Kingdom
2Haematology Department, King's College London, London, United Kingdom
3King's College London, London, United Kingdom
4Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
5King's College Hospital, London, United Kingdom
6NIHR GSTT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom
7Vanderbilt University, Nashville, TN
8GKT School of Medicine, London, United Kingdom

Marianna Rossi, MD1*, Giorgio Croci2,3*, Emanuela Boveri4*, Umberto Gianelli5*, Maurilio Ponzoni, MD6, Laura Giordano7*, Marta Ubezio, MD8*, Erica Travaglino9*, Lucio Morabito7*, Chiara Milanesi7*, Elena Saba7*, Lorenza Borin, MD10*, Massimo Bernardi11*, Valeria Santini, MD 12, Maria Teresa Voso, M.D.13, Susanna Fenu14*, Attilio Orazi, MD15*, Armando Santoro, MD16*, Andrea Bacigalupo, MD17, Alessandro Rambaldi, MD, Prof18 and Matteo Giovanni Della Porta, MD7*

1IRCCS Policlinico S. Matteo, Pavia, Italy
2Division of Pathology, Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy
3Department of Pathology, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
4Unit of Pathology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
5Division of Pathology, University of Milan, IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, Milan, Italy
6San Raffaele H. Scientific Institute, Milan, Italy
7Cancer Center, Humanitas Research Hospital and Center for Accelerating Leukemia Research (CALR), Humanitas University, Milan, Italy
8SC Ematologia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9Department of Hematology Oncology, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
10San Gerardo Hospital, Monza, Italy
11San Raffaele Scientific Institute, Milano, ITA
12Azienda Ospedaliero Universitaria Careggi, Florence, Italy
13Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy
14Hematology Dep. Az. Osp. San Giovanni-Addolorata Rome, Italy, Rome, Italy
15Weill Cornell Medical College, New York, NY
16Cancer Center, Humanitas Research Hospital, Humanitas University, Milan Italy, ROZZANO, Italy
17Institute of Hematology, Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy
18Hematology and Bone Marrow Transplant Unit, University of Milan, ASST Papa Giovanni XXIII, Bergamo, Italy

Madeline Niederkorn, BS1,2, Melinda Varney, PhD1*, Ken Greis, PhD3*, Ruhikanta A. Meetei, PhD1*, Kwangmin Choi, PhD1* and Daniel Starczynowski, PhD 1,2

1Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Department of Cancer Biology, University of Cincinnati, Cincinnati, OH
3Department of Cancer Biology, University of Cincinnati, Cincinnati

Jack Khouri, MD1, Vera Adema, PhD2*, Ying Ni, PhD3*, Heesun J. Rogers, MD, PhD4, Bartlomiej P. Przychodzen, MSc5*, Cassandra M. Hirsch, BS5*, Elise Lemelle, BS5*, Teodora Kuzmanovic, BA5*, Anjali S. Advani, MD6, Aaron T. Gerds, MD, MS7, Sudipto Mukherjee, MD, PhD, MPH6, Aziz Nazha, MD7, Yogenthiran Saunthararajah, MD5, Yazan F. Madanat, MD7, Bhumika J. Patel, MD8, Francesc Sole, PhD9, Steffan T. Nawrocki, PhD10, Jennifer Carew, PhD11*, Matt Kalaycio, MD7, Mikkael A. Sekeres, MD, MS6, Jaroslaw P. Maciejewski, PhD, MD, FACP 7, Valeria Visconte, Ph.D.5 and Hetty E. Carraway, MD, MBA7

1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Translational Hematology and Oncology, Cleveland Clinic, Cleveland, OH
3Center for Clinical Genomics, Cleveland Clinic, Cleveland, OH
4Department of Hematopathology, Cleveland Clinic, Cleveland, OH
5Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Leukemia Program, Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
7Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH
8Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
9MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
10University of Arizona Cancer Center, Tucson, AZ
11Hematology and Oncology, University of Arizona Cancer Center, Phoenix, AZ

Claudia Haferlach, MD, Wencke Walter, PhD*, Anna Stengel, PhD, Niroshan Nadarajah*, Wolfgang Kern, MD, Manja Meggendorfer, PhD and Torsten Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

*signifies non-member of ASH